Distinct muscle imaging patterns in myofibrillar myopathies by Fischer, D. et al.

























Objective: To compare muscle imaging findings in different subtypes of myofibrillar myopathies
(MFM) in order to identify characteristic patterns of muscle alterations that may be helpful to
separate these genetic heterogeneous muscular disorders.
Methods: Muscle imaging and clinical findings of 46 patients with MFM were evaluated (19
desminopathy, 12 myotilinopathy, 11 filaminopathy, 1 B-crystallinopathy, and 3 ZASPopathy).
The data were collected retrospectively in 43 patients and prospectively in 3 patients.
Results: In patients with desminopathy, the semitendinosus was at least equally affected as the
biceps femoris, and the peroneal muscles were never less involved than the tibialis anterior (sen-
sitivity of these imaging criteria to detect desminopathy in our cohort 100%, specificity 95%). In
most of the patients with myotilinopathy, the adductor magnus showed more alterations than the
gracilis muscle, and the sartorius was at least equally affected as the semitendinosus (sensitivity
90%, specificity 93%). In filaminopathy, the biceps femoris and semitendinosus were at least
equally affected as the sartorius muscle, and the medial gastrocnemius was more affected than
the lateral gastrocnemius. The semimembranosus mostly showed more alterations than the ad-
ductor magnus (sensitivity 88%, specificity 96%). Early adult onset and cardiac involvement was
most often associated with desminopathy. In patients with filaminopathy, muscle weakness typi-
cally beginning in the 5th decade of life was mostly pronounced proximally, while late adult onset
(50 years) with distal weakness was more often present in myotilinopathy.
Conclusions: Muscle imaging in combination with clinical data may be helpful for separa-
tion of distinct myofibrillar myopathy subtypes and in scheduling of genetic analysis.
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GLOSSARY
IF  intermediate filament; MFM  myofibrillar myopathies.
Desmin-related myopathy was initially described as a progressive muscular disorder often associated
with cardiomyopathy and histopathologically characterized by aberrant desmin aggregation in abnormal
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other proteins besides desmin prompted the non-
committal term myofibrillar myopathy (MFM).2-4
Mutations in the human desmin gene (DES) on
chromosome 2q35 were first shown to be associ-
ated with MFM.5-7 Desmin is the main intermedi-
ate filament (IF) in skeletal and cardiac muscle. It
forms a three-dimensional scaffold around myofi-
brillar Z-discs thereby connecting the myofibrils to
the subsarcolemmal cytoskeleton.810 Another
MFM form is associated with mutations in the
gene encoding B-crystallin (CRYAB), a chaper-
one that normally stabilizes desmin filaments and
prevents their aggregation.11 More recently, muta-
tions in the human Z-disc proteins myotilin
(MYOT), ZASP (LDB3), and filamin C (FLNC)
have also been shown to cause MFM.12-15 If a
mutation in one of these five genes can be identi-
fied, the MFM subtype is designated according to
the affected protein as desminopathy, B-
crystallinopathy, myotilinopathy, filaminopathy,
or ZASPopathy.
The diagnosis of MFM is defined by his-
topathologic criteria.2-4 However, a differentiation
between the MFM subtypes on pathology findings
alone is not possible. The time-consuming hsp27-
2D-gel electrophoresis has been shown to be a use-
ful diagnostic tool but only for differentiating
desminopathies from other forms of MFM.16
Clinical presentation of MFM has been very
variable.6,12-19 Weakness of proximal and distal
muscles of lower and upper limbs may occur in
each MFM subtype. Individual distribution pat-
tern of muscle weakness overlaps between the
MFM subtypes and large interindividual variation
has been observed even in patients with identical
mutation.20 Practically, a definite determination of
MFM subtype can only be established by means of
direct gene sequencing.
Muscle imaging by MRI or CT has become a
very useful tool in clarification of neuromuscular
disorders and is performed routinely in many
neuromuscular centers. The aim of the present
study was to compare muscle imaging findings
in desminopathy, B-crystallinopathy, myotili-
nopathy, filaminopathy, and ZASPopathy and
to search for characteristic radiologic patterns
that may help to differentiate subtypes of MFM
and to schedule genetic analyses.
METHODS Patients and molecular genetic analysis. A
total of 46 patients were examined, including 19 patients with
desminopathy from 13 different families, 12 patients with myo-
tilinopathy from 4 unrelated families, 11 filaminopathy patients
from 3 families sharing a common founder mutation, 3 patients
with ZASPopathy, and 1 patient with B-crystallinopathy.
DNA extraction from blood samples and DES, MYOT, FLNC,
LDB3, and CRYAB mutation analysis were performed by stan-
dard procedures as described for each gene.10-12,15,17 Detailed ge-
netic and clinical data of all patients are given in the table. All
patients were fully cooperative and had given written consent for
genetic and muscular imaging examinations.
Muscle imaging. Muscle imaging data were collected retro-
spectively in 43 patients and in a prospective manner in 3 pa-
tients. Muscle imaging included CT or MRI scans of the pelvis,
thigh, and lower leg muscles, with some variations depending on
the facilities at the performing radiologic department or individ-
ual patient conditions (e.g., pacemaker prohibiting MRI). Scans
were performed at the pelvis (middle of the inguinal ligament
and 5 cm below), thigh (largest diameter of the thigh and 5 cm
below), and calf (largest diameter of the lower leg and 5 cm
below) levels. Each muscle was evaluated at both scan levels on
both sides to stage the level of muscular involvement.21-24 The
degree of muscle degeneration was evaluated according to a
modified 5-point scale.25-27 Stage 0 is referred to a normal appear-
ance; stage 1 (mild) to traces of decreased signal density on CT
or increased signal intensity on the T1-weighted MR sequences;
stage 2 (moderate) to decreased signal density on CT increased
signal intensity (MRI) with beginning confluence in less than
50% of the muscle; stage 3 (severe) to decreased signal density
(CT) or increased signal intensity (MRI) in more than 50% of
an examined muscle; and stage 4 (end-stage disease) to a state
when the entire muscle is replaced by lower density (CT) or
increased signal intensity (MRI).
Statistical analysis. To compare the involvement of different
muscles (rated on 5-point scale) within the desminopathy, myo-
tilinopathy, and filaminopathy groups, the Wilcoxon matched
pairs test at significance level 0.05 was used. For evaluation of
differences between the groups, the scores on the 5-point scale
were converted into relative values by dividing these scores by
the mean value (on 5-point scale) of all affected muscles, calcu-
lated separately for each patient. Thus, values less than one indi-
cated a below average involvement, higher values an above
average involvement. For statistical evaluation, the nonparamet-
ric Mann–Whitney U test at significance level 0.05 was used.
Specificity, sensitivity, and correct classification rate for imaging
criteria of desminopathy, myotilinopathy, and filaminopathy
were calculated using 2  2 contingency tables. Patients with
incomplete imaging data of the muscles included in the criteria
were not considered for this analysis (for details see table e-1 on
the Neurology® Web site at www.neurology.org).
RESULTS Muscle imaging. Details of muscle in-
volvement scores of each patient and mean muscle
involvement of each muscle are provided in table e-1.
A comparison of absolute and relative muscle in-
volvement between MFM subtypes (desminopathy,
myotilinopathy, filaminopathy) is shown in table
e-2. Table e-3 shows a comparison of muscles and
table e-4 a comparison of muscle groups within the
MFM subtypes. Muscle imaging criteria for separa-
tion of different MFM subtypes are provided in
table e-5.
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Table Summary of genetic and clinical data of all patients included








(ref.*) Hip Knee Ankle
Distal vs
proximal Cardiomyopathy Pacemaker
1 (5) F † 27 DES R350P F Ab F E D  
2 M † 18 DES E245D (33) F  F E P  D  
3 (5) M † 30 DES R350P F  E Ab F E  F D  P  
4 (34) M 22 25 DES P419S    E  F D  
5 (34) M 25 27 DES I367F    E  F D  
6 (28) M 14 24 DES R406W F  F  E E  F D  P  
7 F 53 54 DES E245D (33)       
8 (29) F 31 40 DES D399Y    E D  
9 (29) M 43 46 DES L338R     D  P  
10 M 38 42 DES E245D (33) F  E  F E  F D  P  
11 (34) F 29 49 DES P419S    E  F D  
12 M 38 48 DES S21 (8) NA NA NA NA NA NA NA
13 (28) F 16 27 DES R406W F Ab F  E E  F D  P  
14 (5) F 44 53 DES R350P F NA  E  F P  D  
15 (29) M 34 39 DES D399Y     D  P  
16 F 41 56 DES L338R (29) F Ab  Ad F E P  D  
17 (30) F 36 51 DES Del (Asp366) F  E Ab  Ad F  E F  E P  D  
18 (29) M 41 53 DES L377P NA NA NA NA NA  
19 M 40 57 DES L338R (29) F  E Ab  Ad F  E F  E P  D  
20 F NA NA CRYAB R120G (11) NA NA NA NA NA NA NA
21 F 50 53 MYOT S55F (32)    E  F D  
22 (12) M 51 57 MYOT S55F   F  E E  F D  P  
23 (12) F 67 72 MYOT S55F    E  F D  
24 (12) M 51 62 MYOT S55F F  E Ab  Ad F  E E  F P  D  
25 (12) F 69 76 MYOT S55C F Ab F  E E  F D  P  
26 (12) F 48 58 MYOT S55F F  E Ab  Ad F  E E  F D  P  
27 (12) M 50 52 MYOT S55F F  E Ab  Ad F  E E  F D  P  
28 M 49 56 MYOT S55F (32)   F  E E  F D  P  
29 (12) F 58 69 MYOT S55C F  E Ab  Ad F  E E  F D  P  
30 F 58 68 MYOT S60C (13) F  E Ab  Ad F  E E  F D  P  
31 (25) M 50 62 MYOT S55F F  E Ab  Ad F  E E  F D  P  
32 (12) F 47 69 MYOT S55F F  E Ab  Ad F  E E  F P  D  
33 (19) F † 25 FLNC W2710X       
34 (19) M 40 48 FLNC W2710X NA NA NA NA NA  
35 (19) M 45 49 FLNC W2710X E  F Ab  Ad E  F E  F P  D  
36 (19) F 49 56 FLNC W2710X E  F  E  F E  F P  D  
37 (19) M 57 60 FLNC W2710X     P  D  
38 (19) F 42 45 FLNC W2710X E  F Ab  Ad E  F E  F P  D  
39 (19) F 44 52 FLNC W2710X E  F Ab  Ad E  F E  F P  D  
40 (19) F 49 54 FLNC W2710X     P  
41 (19) M 45 58 FLNC W2710X     P  D  
42 (19) M 37 64 FLNC W2710X     P  D  
43 (19) F 40 56 FLNC W2710X NA NA NA NA NA  
44 (17) F † 54 ZASP A165V   F  E E  F D  
45 (17) F 50 70 ZASP A165V E  F Ab  Ad  F  E D  P  
46 M 27 66 ZASP A147T (14)    E D  P  
*In parentheses is the reference number where more detailed clinical findings of the patient can be obtained or where the
mutation was first described.
†No complaints.
F  flexion; Ab  abduction; E  extension; D  distal; P  proximal; Ad  adduction; NA  not available;   present;  
absent.
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Desminopathy. Muscle imaging findings of pa-
tients with desminopathy ranging from mild to se-
vere involvement are shown in figure 1. Pelvic
muscles: the gluteus maximus muscle was signifi-
cantly more involved than the gluteus medius and
minimus muscles. Thigh: semitendinosus, sartorius,
and gracilis were the most affected muscles exceeding
the involvement of the adductor magnus, biceps femo-
ris, and semimembranosus. The anterior compartment
(rectus femoris, vastus lateralis, intermedius, and medi-
alis) was relatively spared in most patients. Lower legs:
the peroneal muscles displayed significantly more lipo-
matous changes than the tibialis anterior and muscles of
the posterior compartment (soleus, medial, and lateral
gastrocnemius). Mean involvement of distal muscles
slightly, but significantly, exceeded proximal muscles
(thigh and pelvis).
B-crystallinopathy. Muscle imaging findings in
a patient with a R120G BC mutation are given in
figure e-1 and were very similar to patients with
desminopathy. The most involved muscles were the
gluteus maximus, sartorius, semitendinosus, gracilis,
and the peroneal muscles.
Myotilinopathy. Muscle imaging in patients with
myotilinopathy is illustrated in figure 2. Pelvic mus-
cles: the available data were not sufficient for statisti-
cal analysis. However, the gluteus maximus was less
involved than the gluteus medius and minimus mus-
cles in two out of three patients examined. Thigh:
adductor magnus, biceps femoris, vastus medialis,
semimembranosus, and vastus intermedius were the
most involved muscles. Vastus lateralis, semitendino-
sus, gracilis, and rectus femoris were least affected.
Lower legs: soleus and medial gastrocnemius showed
Figure 1 Patients with desminopathy
Muscular CT imaging ranging from clinically mild to more severe involvement of the pelvis (A–D), thigh (E–H), and lower legs
(I–L) muscles with a characteristic temporal pattern of muscle atrophy. In the pelvis, mild changes first appeared in the
gluteus maximus (A), later in gluteus minimus (B,C), while the gluteus medius muscles is also involved in very advanced
patients (D). In the thigh, the earliest and always most severely affected muscle is the semitendinosus (E), followed by
sartorius, gracilis (F, G), and to a milder degree adductor magnus and quadriceps muscles, while semimembranosus and
biceps femoris are relatively preserved for a long time (F, G), before in severely affected patients marked degeneration is
observed in all muscles (H). In the lower legs, first changes appeared in the peroneal muscles (I), followed by involvement of
the tibial anterior (J), and later gastrocnemius and soleus muscles in more severely affected patients (K, L).
Figure 2 Patients with myotilinopathy
Muscle CT imaging ranging from mild to severe involvement of the thigh (A–C) and lower legs (D–F). Semimembranosus,
biceps femoris, and adductor magnus of the thigh show early changes (A, B), followed by the vastus intermedius and vastus
medialis muscles (B, C). Semitendinosus, rectus femoris, sartorius, and gracilis are relatively spared (C). In the lower legs,
the soleus (D) and later tibial anterior and medial gastrocnemius muscles are the earliest and most affected muscles (E).
Peroneal muscles and lateral gastrocnemius are relatively spared even in more severely affected patients (F).
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more alterations than the lateral gastrocnemius. The
soleus was also more affected than the peroneal mus-
cles and tibialis anterior muscle. In general, distal
muscle involvement was significantly greater than
proximal muscle affection.
Filaminopathy. Muscle images are provided in figure
3. Pelvic muscles: the available data were not sufficient
for statistical analysis. One patient had less involvement
of the gluteus maximus compared to gluteus minimus
and medius muscles. Thigh: the semimembranosus, bi-
ceps femoris, adductor magnus, vastus intermedius, and
medialis were most affected, whereas sartorius, gracilis,
and rectus femoris were relatively spared. Lower legs:
soleus and medial gastrocnemius were significantly
more affected than lateral gastrocnemius and peroneal
muscles.
ZASPopathy. Muscle imaging findings in a patient
with an A147T ZASP mutation are shown in figure
4. Data were not sufficient for statistical analysis. In
the pelvis, gluteus minimus was most affected in all
three patients. At the thigh level, the posterior com-
partment (biceps femoris and semimembranosus)
was mostly involved whereas adductor magnus and
gracilis were relatively spared. In the lower legs, one
patient presented only with alterations in the soleus
and medial gastrocnemius muscle at onset of the dis-
ease. In one case, the soleus was most affected and in
the third one, all lower leg muscles showed distinct
changes.
Clinical data and correlation of manual muscle testing
to muscle imaging findings. The mean age at onset
was in desminopathy 33.4  10.3 years (range, 14 to
53 years), myotiliopathy 54.4  7.2 years (range, 47
to 69 years), in filaminopathy 44.3  5.6 years
(range, 37 to 54 years), and in ZASPopathy 43 years.
Cardiomyopathy was present in 8 and a pacemaker
in 5 of 18 patients with desminopathy. In contrast,
cardiomyopathy was much less common in filamin-
opathy and myotilinopathy and none of the patients
without desminopathy had a pacemaker.
Complete data of muscle weakness at time of MRI
or CT examination were available for 15 patients with
desminopathy, 12 patients with myotilinopathy, 4 pa-
tients with filaminopathy, and 3 patients with
ZASPopathy (table). In desminopathy, myotilinopathy,
and filaminopathy, manual muscle testing showed a
greater impairment of knee flexion as compared to knee
extension in more than half of the patients with weak-
ness of thigh muscles. In the remaining patients, knee
extension and flexion were similarly affected. Consis-
tent with these findings muscle imaging studies revealed
that posterior compartment of the thigh (mean involve-
ment of semimembranosus, semitendinosus, and biceps
femoris) was significantly more affected than the ante-
rior compartment (mean involvement of sartorius, rec-
tus femoris, vastus lateralis, intermedius, and medialis)
in these MFM subtypes. Foot dorsiflexion was more
impaired than plantarflexion in 12 out of 15 patients
with desminopathy and all patients with myotilinopa-
thy and filaminopathy with complete clinical data. In
contrast, muscle imaging studies in patients with myoti-
linopathy and filaminopathy showed significantly more
alterations in soleus muscle, one of the main plantar
flexors, compared to tibialis anterior. The impairment
Figure 3 Patients with filaminopathy
Muscle MR imaging ranging from mild to severe involvement of the pelvis (A–C), thigh (D–F), and lower legs (G–I). In the
pelvis, initial changes are relatively mild (A, B), later in the course of illness the extent of degeneration in the gluteus minimus
and medius muscles becomes greater than in the gluteus maximus (C). In the thigh, the vastus intermedius and medialis,
adductor magnus, semimembranosus, and biceps femoris muscles show early and most severe changes (D, E). Semitendi-
nosus, rectus femoris, sartorius, and gracilis are relatively spared (F). In the lower legs, the earliest affected muscles are
soleus (G), and later tibial anterior and medial gastrocnemius muscles (H). Even in more advanced disease peroneal muscles
and lateral gastrocnemius are relatively spared (I).
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of plantarflexion due to affection of soleus may be partly
compensated by significantly lesser involvement of lat-
eral gastrocnemius (compared to tibialis anterior). In
addition, distal weakness predominated in 11 patients
with desminopathy, while in 5 patients proximal mus-
cles were equally or more involved than distal muscles.
In myotilinopathy, 11 patients had more distal than
proximal weakness, and 1 had equal distal and proximal
weakness. In 7 filaminopathy patients, proximal mus-
cles were equally or more involved than distal muscles.
All three patients with ZASP presented with predomi-
nant distal weakness.
DISCUSSION In this study we performed a system-
atic retrospective muscle imaging assessment in a
large series of 43 patients and a prospective evalua-
tion of 3 patients with genetically proven MFM sub-
types. Different characteristic patterns of muscle
involvement in desminopathy, myotilinopathy, and
filaminopathy were observed which in combination
with clinical data may be helpful to distinguish these
subtypes from other MFM forms.
In particular in desminopathy, the clinical pheno-
type can be very variable. However, our muscle imag-
ing studies revealed some common findings in patients
with desminopathy presenting with different muta-
tions, disease progression, and distribution of muscle
weakness. In all of these patients, the semitendinosus
was at least equally affected as the biceps femoris, and
the peroneal muscles were never less involved than the
tibialis anterior. Regarding the other MFM subtypes,
only the patient with BC mutation and one patient
with myotilinopathy fulfilled these criteria. Therefore,
the sensitivity and specificity for detection of
desminopathy using these criteria were very high in our
cohort (table e-5). This characteristic pattern was also
observed in MRI images of three patients who harbored
the same R350P mutation in DES but presented with
very different clinical phenotypes.20 In contrast, patients
with mutations in the myotilin, filamin C, and ZASP
genes presented with clearly distinctive patterns of mus-
cular involvement. Most of the patients with myotili-
nopathy had a greater involvement of the adductor
magnus compared to the gracilis muscle, and the sarto-
rius muscle was at least equally affected as the semiten-
dinosus. Regarding the other MFM groups, only one
patient with desminopathy and one with filaminopathy
showed such a combination. In filaminopathy, the bi-
ceps femoris and the semitendinosus were at least
equally affected as the sartorius muscle, and the medial
gastrocnemius was always more affected than the lateral
gastrocnemius. In all patients with filaminopathy except
one, the semimembranosus was equally or more in-
volved than the adductor magnus. According to the
other MFM subgroups, only one patient with
desminopathy showed this pattern. Therefore, the sen-
sitivity and specificity of the imaging criteria for separat-
ing myotilinopathy and filaminopathy were also high in
our cohort (table e-5). After defining these differentiat-
ing criteria, we have identified three additional patients
with MFM (14, 21, 36 in the table). They presented
with mutations in DES, MYOT, and FLNC. Each of
them fulfilled the imaging criteria of the respective
MFM subgroup.
Muscle imaging is nowadays often used in neuro-
muscular centers before performing a muscle biopsy to
select the most suitable muscle for analysis. Further-
more, muscle imaging in combination with clinical ex-
amination has been useful in order to characterize the
phenotype of muscular disorders and may be helpful in
assessing follow-up. The results of our study indicate
that muscle imaging may also be a useful tool for sepa-
rating genetically distinct forms of MFM. The criteria
mentioned above to differ between the MFM subtypes
are practically not testable by clinical examination
alone. This emphasizes that assessment of individual
muscles, that are part of compound muscle actions, is
much more reliable by imaging.
However, there are some limitations of this study.
First, the data were collected retrospectively in most
cases and patients with unknown causative mutation
Figure 4 Muscle MR imaging of a patient with ZASPopathy
In the pelvis, the gluteus maximus and minimus muscles were the most affected (A). In the
thigh, adductor magnus, vastus medialis, vastus intermedius, biceps femoris, and semi-
membranosus were clearly involved (B). In the lower legs, the soleus muscle was the most
affected (C).
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have not been considered. Therefore, the criteria that
have been defined for separating MFM subgroups
must be verified in a prospective study. In addition,
it can be intricate to perform muscle imaging to
schedule molecular genetic testing after a diagnosis of
MFM is made by biopsy. Furthermore, the presence
of a pacemaker generally prohibits MRI studies while
CT scans have less contrast and involve radiation ex-
posure. Muscle imaging can be much less useful in
asymptomatic patients or in patients in very early
disease stages as it might not show any involvement
(e.g., patient 33 with filaminopathy) or only alter-
ations of a single muscle (soleus in myotilinopathy31 )
not being sufficient for a correct classification. Also,
patients in very advanced stages with severe muscle
degeneration may not show a distinctive pattern.
Clinical findings besides muscle imaging may also
be useful for the differentiation of MFM subtypes.
Clinical data of our study and previous reports12-
14,17-20 indicate that patients with MFM with cardiac
involvement, especially arrhythmogenic cardiomy-
opathy requiring pacemaker implantation, and early
adult onset before the age of 40 are more likely to
have desminopathy. Patients with MFM with onset
in the 5th decade of life and muscle weakness more
pronounced proximally than distally are more likely
to have filaminopathy, while distal myopathy is more
often seen in ZASPopathy and myotilinopathy. In
the latter, first clinical symptoms mostly occur above
the age of 50 years.
Muscle imaging in combination with clinical data
may be helpful for separation of genetic distinct sub-
forms of MFM and to schedule molecular genetic
testing.
Received November 12, 2007. Accepted in final form May 29,
2008.
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